EP Patent

EP3150197A1 — Solid forms of bendamustine hydrochlorid

Assigned to Cephalon LLC · Expires 2017-04-05 · 9y expired

What this patent protects

Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.

USPTO Abstract

Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.

Drugs covered by this patent

Patent Metadata

Patent number
EP3150197A1
Jurisdiction
EP
Classification
—
Expires
2017-04-05
Drug substance claim
No
Drug product claim
No
Assignee
Cephalon LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.